Anticonvulsant Drugs Market to Surpass US$ 8,030.4 Million by 2030, Says Coherent Market Insights (CMI)
February 22, 2023 09:15 ET
|
CMI
Burlingame, Feb. 22, 2023 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global anticonvulsant drugs market is estimated to be valued at US$ 6,757.8 in 2022 and is expected to...
CBD Gummies Market Size ($12.18 Billion) Growth Forecasts at 28.3% of CAGR during 2021 to 2028 – Global Analysis by The Insight Partners
January 31, 2023 09:55 ET
|
The Insight Partners
New York, Jan. 31, 2023 (GLOBE NEWSWIRE) -- According to The Insight Partners, “CBD Gummies Market Size, Share, Growth, Trends and Global Forecast to 2028 - COVID-19 Impact and Global Analysis By...
Canadian Men’s Health Foundation expands MindFit Toolkit to support more men with anxiety and depression
January 19, 2023 08:00 ET
|
Canadian Men's Health Foundation
VANCOUVER, British Columbia, Jan. 19, 2023 (GLOBE NEWSWIRE) -- The Canadian Men’s Health Foundation (CMHF) announced today new and expanded mental health resources for their MindFit Toolkit...
Independent data review commences for Phase 2 trial of psilocybin-assisted psychotherapy for anxiety
January 18, 2023 08:00 ET
|
Incannex Healthcare
MELBOURNE, Australia, Jan. 18, 2023 (GLOBE NEWSWIRE) -- Incannex Healthcare Limited (Nasdaq: IXHL) (ASX: IHL), (‘Incannex’ or the ‘Company’), a pharmaceutical company developing proprietary...
Mental Health Technologies Celebrates Mental Wellness Month
January 17, 2023 15:00 ET
|
Mental Health Technologies (MHT)
AURORA, Ill., Jan. 17, 2023 (GLOBE NEWSWIRE) -- At Mental Health Technologies (MHT), they bring awareness to mental health concerns daily. However, each year everyone goes from the hustle and bustle...
Gb Sciences Addresses Growing Need for Anxiety and Depression Medications With Non-Psychedelic, Kava-Based Formulations
December 12, 2022 07:00 ET
|
Gb Sciences
LAS VEGAS, Dec. 12, 2022 (GLOBE NEWSWIRE) -- Gb Sciences, Inc. (OTCQB:GBLX), a leading plant-inspired, biopharmaceutical research and development company, is addressing the growing need for anxiety...
Global Mindfulness Meditation Application Markets, 2022-2028: Increasing Focus on Personalization with Opportunities in the Incorporation of AI & ML in Meditation Apps and Need for Self-Regulation
December 09, 2022 04:43 ET
|
Research and Markets
Dublin, Dec. 09, 2022 (GLOBE NEWSWIRE) -- The "Mindfulness Meditation Application Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Operating System and End User" report has been...
Psychiatric Times Announces the Addition of the Anxiety and Depression Association of America to its Strategic Alliance Partnership Program
December 06, 2022 14:15 ET
|
Psychiatric Times™
CRANBURY, N.J., Dec. 06, 2022 (GLOBE NEWSWIRE) -- Psychiatric Times™, the #1 psychiatric publication in the United States, today announced that it has added the Anxiety and Depression Association of...
EATING RECOVERY CENTER AND PATHLIGHT MOOD & ANXIETY CENTER INVESTS IN TEAMMATE ENGAGEMENT TO ADVANCE ITS MISSION OF OFFERING THE HIGHEST QUALITY CLINICAL CARE FOR PATIENTS WITH EATING DISORDERS AND MOOD AND ANXIETY DISORDERS
December 05, 2022 08:00 ET
|
Eating Recovery Center
Denver, Colorado, Dec. 05, 2022 (GLOBE NEWSWIRE) -- Eating Recovery Center and Pathlight Mood & Anxiety Center (ERC Pathlight), the nation’s leading mental health care system dedicated to the...
Cingulate Benzinga All Live Access Appearance Rescheduled for December 16
December 01, 2022 14:00 ET
|
Cingulate Inc.
KANSAS CITY, Kan., Dec. 01, 2022 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform...